Spatial overlap of peptide hotspots and canonical drug pockets in a model enzyme. From molecular display peptides to small molecule inhibitors.

Size: px
Start display at page:

Download "Spatial overlap of peptide hotspots and canonical drug pockets in a model enzyme. From molecular display peptides to small molecule inhibitors."

Transcription

1 partnerships in biologics discovery Spatial overlap of peptide hotspots and canonical drug pockets in a model enzyme Walraj S. Gosal June 205 From molecular display peptides to small molecule inhibitors. In collaboration with: With funding from:

2 Display technology is pivotal for biologics discovery Humira (monoclonal antibody) is the biggest selling drug worldwide ($3bn in sales). Primary seq. 00 amino acid protein = x0 30 sequences Humira FAB Approved: RA, UC, CD fold into precise 3D structures TNFα" chemical reactions of life through the precise arrangement & dynamics of atoms Computational approaches are showing evermore promise (e.g. Rosetta),2. Design Crystal structure Kuhlman,B. et al. Science (2003). 2 Fleishman,S.J. et al. Science (20). 2

3 Display technology is pivotal for the emergence of biologics Recent emergence of over a dozen scaffolds ranging in size (~ 20 to 70 amino acids),2. Humira FAB DARPin Approved: RA, UC, CD TNFα" Anticalin e.g. PRS-050 (Phase I: angiogenesis) e.g. Abicipar pegol (Phase III: macular degeneration) Adnectin / Centyrin e.g. Angiocept (phase II glioblastoma) Affibody e.g. SOBI002 (Phase I: inflammation) Knottin e.g. Ziconotide (Approved: pain relief) Lofblom,J. et al. Current Opinion in Biotechnology (20). 2 Gronwall, C. et al. Journal of Biotechnology (2009).

4 pept random library Display technology is pivotal for biologics discovery Basic idea is to enrich phenotypes in a library and be able to read genotypes. CIS Display2-4 First described by George Smith in 985 using bacterial filamentous phage (phage display). Incubation with PCR amplification of binders random library random library Smith,G.P. 4Patel,S. random library In vitro transcription & translation Science (985). 2Odegrip,R. et al. PNAS (2004).3Eldridge,B. et al. Protein Eng. Des. Eng. (2009). et al. Protein Eng. Des. Eng. (203). 4

5 CIS display & NGS random peptide library selection, amplifiction & NGS. CIS display & NGS Protein VLSEGEWQLVLHVWAKVEADV peptide site I 05 AQGAMNKALELFRKDIAAKYK site II peptide Residue hotspots & field calculation 3. Structure determination Computation (mutational analysis, Rosetta, & XED force field) (NMR or X-ray) VLSEGEWQLVLHVWAKVEADV 05 AQGAMNKALELFRKDIAAKYK site II h2 5. Virtual molecule (>07 small m -ve/hbd h3 Target-binding peptide candidates 2. Peptide hit validation (ELISA, truncation, binding, activity, epitope mapping) h & screening site I random peptide library Small&-binding peptides 4. selection, amplifiction NGS 2. Peptide hit validation (ELISA, truncation, binding, activity, epitope mapping). CIS display & NGS Target-binding peptide candidates rget X-ray / NMR Can molecular display be used to inform small molecule discovery? VdW surface h4 +ve/hba hydrophobic Small -binding peptides 3. Structure determination (NMR or X-ray) Peptide field map 6. Focused experimental screen O H N NH O H N OH O

6 Target of choice: thrombin - a serine protease 40 year race in the drug industry to replace anticoagulants - Warfarin (953) & Heparin (937),2. Large body of public information that covers all major discovery platforms (fragment screening, structurebased design & HTS). S S S S2 S4 S2 S4 S2 S4 Substrate: FPA Dabigatran Melagatran Unique structure based solutions from Nature 3. s-variegin 3 (32 aa) Tropical bont tick Anophelin 3 (3 aa) Mosquito Hirudin 3 (65aa) Medicinal leech Gustafsson,D. Nature Reviews Drug Discovery (2004). 2 Nar, H. Trends in Pharm. Sci (202). 3 Huntington, J. A. Thromb. Haemost., (204). 6

7 Summary & Acknowledgements. In a retrospective study, CIS display peptide hot-spots spatially overlap with known drug pockets in thrombin, although novel pockets are induced. 2. Peptides cover the chemical solution space for the primary S pocket. 3. Field patterns based on peptides can be used to find new inhibitors. Chris Ullman Neil Cooley Kevin Matthews Gabriela Ivanova Amanda Hallott Shabana Vohra Contact Walraj S. Gosal walraj.gosal@isogenica.com Steve Gardner Dirk Gewert Peter Campbell Robert Scoffin Andy Vinter Mark Mackey Gordon Woodrow Stephan Krapp Tom Blundell Jim Huntington Ty Adams With funding from: 7

A New Peptide Drug Modality; Helix-Loop-Helix Technology. Interprotein Corporation

A New Peptide Drug Modality; Helix-Loop-Helix Technology. Interprotein Corporation A New Peptide Drug Modality; Helix-Loop-Helix Technology Interprotein Corporation 1 Interprotein Corporation Location: Osaka, Japan Year Established: 2001 CEO & President: Masato Hosoda www.interprotein.com

More information

X ray structure data Molecular dynamics simulation Sequence homology Educated guessing. Rational. Protein design

X ray structure data Molecular dynamics simulation Sequence homology Educated guessing. Rational. Protein design Biocatalyst Design Rational X ray structure data Molecular dynamics simulation Sequence homology Educated guessing Protein design Random Do enough mistakes, so many time you are bound to get it right some

More information

Recent Progress of Interprotein s Research Activities. Interprotein Corporation

Recent Progress of Interprotein s Research Activities. Interprotein Corporation Recent Progress of Interprotein s Research Activities - INTENDD and AI-guided INTENDD - Interprotein Corporation 1 Interprotein Corporation Location: Osaka, Japan Year Established: 2001 CEO & President:

More information

Antibodies to Challenging Receptor Targets through NGS and Cell-Based Antibody Phage Panning. Mark Tornetta

Antibodies to Challenging Receptor Targets through NGS and Cell-Based Antibody Phage Panning. Mark Tornetta Antibodies to Challenging Receptor Targets through NGS and Cell-Based Antibody Phage Panning Mark Tornetta Points to convey regarding receptor targets Antigen diversity- cells and engineered ECDs Be creative

More information

Affinity Reagents: The Landscape and Affimer Technology Competitive Advantages

Affinity Reagents: The Landscape and Affimer Technology Competitive Advantages Affinity Reagents: The Landscape and Affimer Technology Competitive Advantages Introduction It is well accepted that the limitations of antibodies present valuable commercial opportunities for alternative

More information

Next-generation analysis of deep sequencing data: Bringing light into the black box of phage display experiments

Next-generation analysis of deep sequencing data: Bringing light into the black box of phage display experiments Next-generation analysis of deep sequencing data: Bringing light into the black box of phage display experiments Dr. Michael Blank (CSO, AptaIT) Biologics 2015; Berlin 02-03 February 1 Accelerating in

More information

Self-financed Coursework Advanced Workshop on Molecular Docking, Virtual Screening & Computational Biology 13 th - 15 th March 2019

Self-financed Coursework Advanced Workshop on Molecular Docking, Virtual Screening & Computational Biology 13 th - 15 th March 2019 Self-financed Coursework Advanced Workshop on Molecular Docking, Virtual Screening & Computational Biology 13 th - 15 th March 2019 Indian Institute of Information Technology- Allahabad Jhalwa Campus,

More information

Comparative Modeling Part 1. Jaroslaw Pillardy Computational Biology Service Unit Cornell Theory Center

Comparative Modeling Part 1. Jaroslaw Pillardy Computational Biology Service Unit Cornell Theory Center Comparative Modeling Part 1 Jaroslaw Pillardy Computational Biology Service Unit Cornell Theory Center Function is the most important feature of a protein Function is related to structure Structure is

More information

Module 2 overview SPRING BREAK

Module 2 overview SPRING BREAK 1 Module 2 overview lecture lab 1. Introduction to the module 1. Start-up protein eng. 2. Rational protein design 2. Site-directed mutagenesis 3. Fluorescence and sensors 3. DNA amplification 4. Protein

More information

Identifying the antibody specificity repertoire

Identifying the antibody specificity repertoire Identifying the antibody specificity repertoire Rafael Smith, Joel Bozekowski, Michael Paul, Patrick Daugherty Department of Chemical Engineering Daugherty Group Gorman Scholar You have a unique antibody

More information

Antibody Discovery at Evotec

Antibody Discovery at Evotec Antibody Discovery at Evotec - Overview - Evotec Antibodies Adding value to our partners research Innovative and flexible solutions from target ID to pre-clinical candidate The people A wide therapeutic

More information

How Targets Are Chosen. Chris Wayman 12 th April 2012

How Targets Are Chosen. Chris Wayman 12 th April 2012 How Targets Are Chosen Chris Wayman 12 th April 2012 A few questions How many ideas does it take to make a medicine? 10 20 20-50 50-100 A few questions How long does it take to bring a product from bench

More information

Contents... vii. List of Figures... xii. List of Tables... xiv. Abbreviatons... xv. Summary... xvii. 1. Introduction In vitro evolution...

Contents... vii. List of Figures... xii. List of Tables... xiv. Abbreviatons... xv. Summary... xvii. 1. Introduction In vitro evolution... vii Contents Contents... vii List of Figures... xii List of Tables... xiv Abbreviatons... xv Summary... xvii 1. Introduction...1 1.1 In vitro evolution... 1 1.2 Phage Display Technology... 3 1.3 Cell surface

More information

COMPAS for the Analysis of SELEX Experiments

COMPAS for the Analysis of SELEX Experiments COMPAS for the Analysis of SELEX Experiments COMPAS (COMmon PAtternS) is a software tool that was especially developed to harness the technology of next generation sequencing (NGS) to bring light into

More information

Prediction of Protein-Protein Binding Sites and Epitope Mapping. Copyright 2017 Chemical Computing Group ULC All Rights Reserved.

Prediction of Protein-Protein Binding Sites and Epitope Mapping. Copyright 2017 Chemical Computing Group ULC All Rights Reserved. Prediction of Protein-Protein Binding Sites and Epitope Mapping Epitope Mapping Antibodies interact with antigens at epitopes Epitope is collection residues on antigen Continuous (sequence) or non-continuous

More information

ProCode TM. Life Science, Inc. A Rapid Flexible MAb-Like Discovery Platform for Creating Diagnostic Antibodies.

ProCode TM. Life Science, Inc. A Rapid Flexible MAb-Like Discovery Platform for Creating Diagnostic Antibodies. ProCode TM A Rapid Flexible MAb-Like Discovery Platform for Creating Diagnostic Antibodies Life Science, Inc. www.meridianlifescience.com Custom Monoclonal Development Meridian Life Science, Inc. (MLS)

More information

Real World Drug Discovery A Chemist's Guide to Biotech and Pharmaceutical Research

Real World Drug Discovery A Chemist's Guide to Biotech and Pharmaceutical Research Real World Drug Discovery A Chemist's Guide to Biotech and Pharmaceutical Research Robert M. Rydzewski ELSEVIER Amsterdam Boston Heidelberg London New York Oxford Paris San Diego San Francisco Singapore

More information

Peptide libraries: applications, design options and considerations. Laura Geuss, PhD May 5, 2015, 2:00-3:00 pm EST

Peptide libraries: applications, design options and considerations. Laura Geuss, PhD May 5, 2015, 2:00-3:00 pm EST Peptide libraries: applications, design options and considerations Laura Geuss, PhD May 5, 2015, 2:00-3:00 pm EST Overview 1 2 3 4 5 Introduction Peptide library basics Peptide library design considerations

More information

Nature inspired design of motif specific antibody scaffolds *

Nature inspired design of motif specific antibody scaffolds * Nature inspired design of motif specific antibody scaffolds * Nature Biotechnology, October 2013, Vol. 31, #10 * Scientific information in the following slides is from this article, if not stated otherwise

More information

Protein isotopic enrichment for NMR studies

Protein isotopic enrichment for NMR studies Protein isotopic enrichment for NMR studies Protein NMR studies ARTGKYVDES sequence structure Structure of protein- ligand, protein-protein complexes Binding of molecules (perturbation mapping) Dynamic

More information

DNA Matters Constructing Genes, Enzymes and Pathways by the Plate

DNA Matters Constructing Genes, Enzymes and Pathways by the Plate DNA Matters Constructing Genes, Enzymes and Pathways by the Plate Leda Notchey May 19, 2015 Agenda 1. The Synthetic Biology Opportunity 2. The Gen9 Advantage 3. Working with Gen9: o o Custom Gene Synthesis

More information

Protein design. CS/CME/BioE/Biophys/BMI 279 Oct. 24, 2017 Ron Dror

Protein design. CS/CME/BioE/Biophys/BMI 279 Oct. 24, 2017 Ron Dror Protein design CS/CME/BioE/Biophys/BMI 279 Oct. 24, 2017 Ron Dror 1 Outline Why design proteins? Overall approach: Simplifying the protein design problem < this step is really key! Protein design methodology

More information

Drug Discovery Targeting the GHKL Superfamily - HSP90, DNA Gyrase, Histidine Kinases

Drug Discovery Targeting the GHKL Superfamily - HSP90, DNA Gyrase, Histidine Kinases Drug Discovery Targeting the GHKL Superfamily - HSP90, DNA Gyrase, Histidine Kinases (Jason) Xinshan Kang, Boris Klebansky, Richard Fine BioPredict, Inc., 660 KinderKamack Rd., radell, NJ 07649 232 nd

More information

Drug Targets - an overview of historical success and protein kinase inhibitors - successes and attrition. John P. Overington

Drug Targets - an overview of historical success and protein kinase inhibitors - successes and attrition. John P. Overington Drug Targets - an overview of historical success and protein kinase inhibitors - successes and attrition John P. Overington jpo@ebi.ac.uk Assay/Target ChEMBL The Organisation of Drug Discovery 1. Scientific

More information

Module 2 overview SPRING BREAK

Module 2 overview SPRING BREAK 1 Module 2 overview lecture lab 1. Introduction to the module 1. Start-up protein eng. 2. Rational protein design 2. Site-directed mutagenesis 3. Fluorescence and sensors 3. DNA amplification 4. Protein

More information

Course Agenda. Day One

Course Agenda. Day One Course Agenda BioImmersion: Biotech for the Non-Scientist A three-day, in-depth course that provides the background required for understanding today s fast-paced biotech marketplace. Beginning with an

More information

Exam MOL3007 Functional Genomics

Exam MOL3007 Functional Genomics Faculty of Medicine Department of Cancer Research and Molecular Medicine Exam MOL3007 Functional Genomics Tuesday May 29 th 9.00-13.00 ECTS credits: 7.5 Number of pages (included front-page): 5 Supporting

More information

TAPBOOST. Breakthrough Platform to Improve Protein Production

TAPBOOST. Breakthrough Platform to Improve Protein Production Breakthrough Platform to Improve Protein Production Protein Folding System and Quality Control System Protein Folding RNA Polypeptide Misfolded Protein Cell Quality Control System Degradation of proteins

More information

Digital Display Libraries using High Density Peptide Arrays Max Bergmann Konferenz XXXVI

Digital Display Libraries using High Density Peptide Arrays Max Bergmann Konferenz XXXVI Digital Display Libraries using High Density Peptide Arrays Max Bergmann Konferenz XXXVI - 2015 Klaus-Peter Stengele, Jigar Patel Roche NimbleGen Inc, Madison, WI www.nimblegen.com Roche NimbleGen Peptide

More information

Introduction to Drug Design and Discovery

Introduction to Drug Design and Discovery Introduction to Drug Design and Discovery Course: Drug Design Course code: 0510412 Dr. Balakumar Chandrasekaran Dr. Bilal Al-Jaidi Assistant Professors, Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy,

More information

Chapter 8 DNA Recognition in Prokaryotes by Helix-Turn-Helix Motifs

Chapter 8 DNA Recognition in Prokaryotes by Helix-Turn-Helix Motifs Chapter 8 DNA Recognition in Prokaryotes by Helix-Turn-Helix Motifs 1. Helix-turn-helix proteins 2. Zinc finger proteins 3. Leucine zipper proteins 4. Beta-scaffold factors 5. Others λ-repressor AND CRO

More information

B. Incorrect! Ligation is also a necessary step for cloning.

B. Incorrect! Ligation is also a necessary step for cloning. Genetics - Problem Drill 15: The Techniques in Molecular Genetics No. 1 of 10 1. Which of the following is not part of the normal process of cloning recombinant DNA in bacteria? (A) Restriction endonuclease

More information

" Rational drug design; a Structural Genomics approach"

 Rational drug design; a Structural Genomics approach " Rational drug design; a Structural Genomics approach" Meeting the need of time; Dr Sanjan K. Das, PhD. Chief Scientific Officer (CSO), BBUK. Institute of Cancer Therapeutics University of Bradford, UK.

More information

QIAGEN s NGS Solutions for Biomarkers NGS & Bioinformatics team QIAGEN (Suzhou) Translational Medicine Co.,Ltd

QIAGEN s NGS Solutions for Biomarkers NGS & Bioinformatics team QIAGEN (Suzhou) Translational Medicine Co.,Ltd QIAGEN s NGS Solutions for Biomarkers NGS & Bioinformatics team QIAGEN (Suzhou) Translational Medicine Co.,Ltd 1 Our current NGS & Bioinformatics Platform 2 Our NGS workflow and applications 3 QIAGEN s

More information

Clamping down on pathogenic bacteria how to shut down a key DNA polymerase complex

Clamping down on pathogenic bacteria how to shut down a key DNA polymerase complex Clamping down on pathogenic bacteria how to shut down a key DNA polymerase complex Bacterial DNA-replication machinery Pathogenic bacteria that are resistant to the current armoury of antibiotics are an

More information

How to Screen a Billion Drug Candidates?

How to Screen a Billion Drug Candidates? How to Screen a Billion Drug Candidates? Single Cell Functional Assays: Ultra-sensitive, Ultra-fast, Ultrahigh-throughput Next-Generation Drug Discovery The advantages of de novo protein engineering for

More information

Combinatorial RNA libraries

Combinatorial RNA libraries SELEX and Artificial Ribozymes Some definitions SELEX: Systematic Evolution of Ligands by EXponential Enrichment (alternatively: in vitro selection, in vitro evolution) Aptamer: nucleic acid ligand (from

More information

Blotting Techniques (Southern blot, Northern blot, Western blot, and Eastern blot)

Blotting Techniques (Southern blot, Northern blot, Western blot, and Eastern blot) Blotting Techniques (Southern blot, Northern blot, Western blot, and Eastern blot) Masheal Aljumaah SEP 2018 Learning Objectives: What is blotting? Blotting Techniques Types. Applications for each technique.

More information

Module I: Introduction

Module I: Introduction Module I: Introduction 20.109 Lecture 1 3 February, 2011 Introduction to: Module Overview Fundamental concepts and techniques in molecular biology Appreciating nucleic acids (RNA in particular) as more

More information

Why do LC MS and LBA

Why do LC MS and LBA Why do LC MS and LBA results differ? A literature evaluation 18 November 2015 Nico van de Merbel An overview In most published BA methods for large molecules, no comparison of platforms (LBA vs LBA, LBA

More information

Custom Antibody Services. Antibodies Designed Just for You. HuCAL Recombinant Monoclonal Antibody Generation Service

Custom Antibody Services. Antibodies Designed Just for You. HuCAL Recombinant Monoclonal Antibody Generation Service Custom Antibody Services Antibodies Designed Just for You HuCAL Recombinant Monoclonal Antibody Generation Service Antibodies Designed Just for You What if there was a technology that would allow you to

More information

SCREENING AND PRESERVATION OF DNA LIBRARIES

SCREENING AND PRESERVATION OF DNA LIBRARIES MODULE 4 LECTURE 5 SCREENING AND PRESERVATION OF DNA LIBRARIES 4-5.1. Introduction Library screening is the process of identification of the clones carrying the gene of interest. Screening relies on a

More information

Protein design. CS/CME/BioE/Biophys/BMI 279 Oct. 24, 2017 Ron Dror

Protein design. CS/CME/BioE/Biophys/BMI 279 Oct. 24, 2017 Ron Dror Protein design CS/CME/BioE/Biophys/BMI 279 Oct. 24, 2017 Ron Dror 1 Outline Why design proteins? Overall approach: Simplifying the protein design problem Protein design methodology Designing the backbone

More information

Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing

Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing Overview Serving biotech and pharma community since 1998 Proven track record of advancing small molecules from

More information

11/22/13. Proteomics, functional genomics, and systems biology. Biosciences 741: Genomics Fall, 2013 Week 11

11/22/13. Proteomics, functional genomics, and systems biology. Biosciences 741: Genomics Fall, 2013 Week 11 Proteomics, functional genomics, and systems biology Biosciences 741: Genomics Fall, 2013 Week 11 1 Figure 6.1 The future of genomics Functional Genomics The field of functional genomics represents the

More information

Selected Techniques Part I

Selected Techniques Part I 1 Selected Techniques Part I Gel Electrophoresis Can be both qualitative and quantitative Qualitative About what size is the fragment? How many fragments are present? Is there in insert or not? Quantitative

More information

New Product: X-Aptamer Selection Kit. Updated April 2015

New Product: X-Aptamer Selection Kit. Updated April 2015 New Product: X-Aptamer Selection Kit Updated April 2015 Technology Basics X-Aptamers are synthetic affinity molecules Similar in function to monoclonal antibodies X-Aptamers combine a variety of chemical

More information

Expressive. Bacterial surface display for the identification of active ingredients for the pharmaceutical and cosmetics industry

Expressive. Bacterial surface display for the identification of active ingredients for the pharmaceutical and cosmetics industry Active Ingredient Research Expressive Bacterial surface display for the identification of active ingredients for the pharmaceutical and cosmetics industry Prof. Dr. Joachim Jose, Institute of Pharmaceutical

More information

Protein design. CS/CME/Biophys/BMI 279 Oct. 20 and 22, 2015 Ron Dror

Protein design. CS/CME/Biophys/BMI 279 Oct. 20 and 22, 2015 Ron Dror Protein design CS/CME/Biophys/BMI 279 Oct. 20 and 22, 2015 Ron Dror 1 Optional reading on course website From cs279.stanford.edu These reading materials are optional. They are intended to (1) help answer

More information

Exam MOL3007 Functional Genomics

Exam MOL3007 Functional Genomics Faculty of Medicine Department of Cancer Research and Molecular Medicine Exam MOL3007 Functional Genomics Thursday December 20 th 9.00-13.00 ECTS credits: 7.5 Number of pages (included front-page): 5 Supporting

More information

Antibody-Antigen recognition. Structural Biology Weekend Seminar Annegret Kramer

Antibody-Antigen recognition. Structural Biology Weekend Seminar Annegret Kramer Antibody-Antigen recognition Structural Biology Weekend Seminar 10.07.2005 Annegret Kramer Contents Function and structure of antibodies Features of antibody-antigen interfaces Examples of antibody-antigen

More information

Using a BioCel System and AssayMap Technology in Phage Display and Antibody Screening. Jason Graves September 20, 2011 AAS User Group Meeting

Using a BioCel System and AssayMap Technology in Phage Display and Antibody Screening. Jason Graves September 20, 2011 AAS User Group Meeting Using a BioCel System and AssayMap Technology in Phage Display and Antibody Screening Jason Graves September 20, 2011 AAS User Group Meeting My Background 15 Years of Automation and Related Experience

More information

ProteoGenix. Life Sciences Services and Products. From gene to biotherapeutics Target Validation to Lead optimisation

ProteoGenix. Life Sciences Services and Products. From gene to biotherapeutics Target Validation to Lead optimisation ProteoGenix Life Sciences Services and Products From gene to biotherapeutics Target Validation to Lead optimisation ProteoGenix Philippe FUNFROCK, founder and CEO French company located in Strasbourg,

More information

Chapter 17. Prediction, Engineering, and Design of Protein Structures

Chapter 17. Prediction, Engineering, and Design of Protein Structures Chapter 17. Prediction, Engineering, and Design of Protein Structures Homologous proteins have similar structure and function Branden & Tooze (1998), Introduction to protein structure, 2 nd ed., p.349.

More information

Evolutionary Methods in B iotechnology

Evolutionary Methods in B iotechnology Evolutionary Methods in B iotechnology Clever Tricks for Directed Evolution Susanne Brakmann I Andreas Schwienhorst 1 Introduction Susanne Brakmann and Andreas Schwienhorst 1 References 3 2 Generation

More information

3D Structure of Biologics in a Convenient Immunoassay Format

3D Structure of Biologics in a Convenient Immunoassay Format 3D Structure of Biologics in a Convenient Immunoassay Format Xing Wang, Ph.D. Array Bridge Inc. 5/25/2017 1 Topics Covered Today Why New Technologies? Technology Development. Case Studies for Novel and

More information

Synthetic Biology. Sustainable Energy. Therapeutics Industrial Enzymes. Agriculture. Accelerating Discoveries, Expanding Possibilities. Design.

Synthetic Biology. Sustainable Energy. Therapeutics Industrial Enzymes. Agriculture. Accelerating Discoveries, Expanding Possibilities. Design. Synthetic Biology Accelerating Discoveries, Expanding Possibilities Sustainable Energy Therapeutics Industrial Enzymes Agriculture Design Build Generate Solutions to Advance Synthetic Biology Research

More information

Application Note AN001

Application Note AN001 Testing hybridoma supernatants with the Spots On Dots Antibody Screening Kit Application Note AN1 Table of Contents Overview... 2 Figure 1. Screening of hybridomas raised against peptide antigens... 3

More information

Opportunities for Accelerating Cell Line Development and Beyond

Opportunities for Accelerating Cell Line Development and Beyond Opportunities for Accelerating Cell Line Development and Beyond European CM&C Strategy Forum May 24, 2017 Christopher Frye, Ph.D. Research Advisor & Group Leader Bioprocess R&D Presentation Outline CM&C

More information

Homology Modelling. Thomas Holberg Blicher NNF Center for Protein Research University of Copenhagen

Homology Modelling. Thomas Holberg Blicher NNF Center for Protein Research University of Copenhagen Homology Modelling Thomas Holberg Blicher NNF Center for Protein Research University of Copenhagen Why are Protein Structures so Interesting? They provide a detailed picture of interesting biological features,

More information

Supplementary Information. Human Antibody-Based Chemically Induced Dimerizers for Cell Therapeutic Applications

Supplementary Information. Human Antibody-Based Chemically Induced Dimerizers for Cell Therapeutic Applications Supplementary Information Human Antibody-Based Chemically Induced Dimerizers for Cell Therapeutic Applications Zachary B Hill 1,4, Alexander J Martinko 1,2,4, Duy P Nguyen 1 & James A Wells *1,3 1 Department

More information

Position1: Senior Scientist/Principal Scientist

Position1: Senior Scientist/Principal Scientist Position1: Senior Scientist/Principal Scientist Field: Immunology, Immuno-Oncology Department: Discovery Biology : o Develop and conduct cell or immune based assays to support drug discovery in cancer

More information

BIRKBECK COLLEGE (University of London)

BIRKBECK COLLEGE (University of London) BIRKBECK COLLEGE (University of London) SCHOOL OF BIOLOGICAL SCIENCES M.Sc. EXAMINATION FOR INTERNAL STUDENTS ON: Postgraduate Certificate in Principles of Protein Structure MSc Structural Molecular Biology

More information

Compound Re-Profiling. Dr Robert Scoffin CEO, Cresset

Compound Re-Profiling. Dr Robert Scoffin CEO, Cresset Compound Re-Profiling Dr Robert Scoffin CEO, Cresset What is it? F F F N N H 2 N S O O Br > Compound Re-Profiling or Re-Purposing is the process of finding a new clinical use for an existing treatment

More information

Translation BIT 220 Chapter 13

Translation BIT 220 Chapter 13 Translation BIT 220 Chapter 13 Making protein from mrna Most genes encode for proteins -some make RNA as end product Proteins -Monomer Amino Acid 20 amino acids -peptides -polypeptides -Structure of Amino

More information

Tools and Technologies for Immunogenicity and Allergenicity Risk Management

Tools and Technologies for Immunogenicity and Allergenicity Risk Management Tools and Technologies for Immunogenicity and Allergenicity Risk Management Dr. Jeremy Fry HESI PATC Symposium on Sensitizing Properties of Proteins 11-13 April 2012 Immunogenicity and Allergenicity Immunogenicity

More information

Phage Display. Tim Clackson ARIAD Pharmaceuticals Inc., 26 Landsdowne Street, Cambridge, MA 02139, USA Henry B. Lowman OXFORD UNIVERSITY PRESS

Phage Display. Tim Clackson ARIAD Pharmaceuticals Inc., 26 Landsdowne Street, Cambridge, MA 02139, USA Henry B. Lowman OXFORD UNIVERSITY PRESS Phage Display Edited by Tim Clackson ARIAD Pharmaceuticals Inc., 26 Landsdowne Street, Cambridge, MA 02139, USA Henry B. Lowman Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA OXFORD UNIVERSITY

More information

In Silico DNA-Based Aptamer Selection and Construction

In Silico DNA-Based Aptamer Selection and Construction In Silico DNA-Based Aptamer Selection and Construction Pete Gannett June 18, 2014 HPC pgannett@hsc.wvu.edu 304.293.1480 (ofc) Outline Introduction to Aptamers 1-D aptamer selection 2-D and 3-D aptamer

More information

The Two-Hybrid System

The Two-Hybrid System Encyclopedic Reference of Genomics and Proteomics in Molecular Medicine The Two-Hybrid System Carolina Vollert & Peter Uetz Institut für Genetik Forschungszentrum Karlsruhe PO Box 3640 D-76021 Karlsruhe

More information

Call for Pilot Project Applications Chemical Biology for Infectious Diseases NIH Center of Biomedical Research Excellence University of Kansas

Call for Pilot Project Applications Chemical Biology for Infectious Diseases NIH Center of Biomedical Research Excellence University of Kansas Call for Pilot Project Applications Chemical Biology for Infectious Diseases NIH Center of Biomedical Research Excellence University of Kansas Applications due: Oct 3 rd, 2016 Anticipated Decision Date:

More information

Pharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001

Pharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001 Pharmacogenetics: A SNPshot of the Future Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001 1 I. What is pharmacogenetics? It is the study of how genetic variation affects drug response

More information

Advanced Therapeutic Antibody Discovery with Multiplexed Screening

Advanced Therapeutic Antibody Discovery with Multiplexed Screening Advanced Therapeutic Antibody Discovery with Multiplexed Screening White Paper Scientists need powerful tools that can deliver results to fully understand the ability of candidate antibodies to interrupt

More information

Pioneering Clinical Omics

Pioneering Clinical Omics Pioneering Clinical Omics Clinical Genomics Strand NGS An analysis tool for data generated by cutting-edge Next Generation Sequencing(NGS) instruments. Strand NGS enables read alignment and analysis of

More information

Therapeutic Proteins BIT 230

Therapeutic Proteins BIT 230 Therapeutic Proteins BIT 230 CLOTTING Haemophilia Benefix Blood Products ANTICOAGULANT THROMBOLYTIC AGENTS tissue plasminogen activator streptokinase Coagulation pathway Factor VIII (Haemophilia A) Factor

More information

Sample Question Paper Session Class XII Biotechnology (045) Marking Scheme

Sample Question Paper Session Class XII Biotechnology (045) Marking Scheme Sample Question Paper Session 2015-16 Class XII Biotechnology (045) Marking Scheme SECTION-A 1. Methylation Student will add a methyl group to one or two bases within the sequence recognized by enzyme.

More information

Enzyme that uses RNA as a template to synthesize a complementary DNA

Enzyme that uses RNA as a template to synthesize a complementary DNA Biology 105: Introduction to Genetics PRACTICE FINAL EXAM 2006 Part I: Definitions Homology: Comparison of two or more protein or DNA sequence to ascertain similarities in sequences. If two genes have

More information

Research in Structural Bioinformatics and Molecular Biophysics. OUTLINE: What is it and why is it useful? EXAMPLES: b. Improving enzyme s function.

Research in Structural Bioinformatics and Molecular Biophysics. OUTLINE: What is it and why is it useful? EXAMPLES: b. Improving enzyme s function. Research in Structural Bioinformatics and Molecular Biophysics OUTLINE: What is it and why is it useful? EXAMPLES: a. Biomolecular surface story. b. Improving enzyme s function. c. Folding proteins. Alexey

More information

Immunogenicity: Assessing the Clinical Relevance and Risk Minimization of Antibodies to Biopharmaceuticals

Immunogenicity: Assessing the Clinical Relevance and Risk Minimization of Antibodies to Biopharmaceuticals Immunogenicity: Assessing the Clinical Relevance and Risk Minimization of Antibodies to Biopharmaceuticals Daniel Kramer/Kathleen Beach Need for public-private collaboration 1 All biopharmaceuticals are

More information

Current Research. Examples of current research projects:

Current Research. Examples of current research projects: Current Research Dr Richard Foster Medicinal Chemistry and Chemical Biology Group Leader Medicinal Chemistry Tutor School of Chemistry University of Leeds r.foster@leeds.ac.uk +44 (0)1133435759 Our group

More information

Applying Affimers. Dr Amanda Nicholl at Avacta Life Sciences. Improving Antibody PK Assay Development

Applying Affimers. Dr Amanda Nicholl at Avacta Life Sciences. Improving Antibody PK Assay Development Improving Pharmacokinetic Assays in a Regulatory Bioanalysis Setting Applying Affimers With an increasing number of antibody-based therapeutics entering the clinic, the need for validated anti-idiotypic

More information

In vitro mutagenesis

In vitro mutagenesis Core course BMS361N Genetic Engineering In vitro mutagenesis Prof. Narkunaraja Shanmugam Dept. Of Biomedical Science School of Basic Medical Sciences Bharathidasan University In vitro mutagenesis Many

More information

The Biotechnology Toolbox

The Biotechnology Toolbox Chapter 15 The Biotechnology Toolbox Cutting and Pasting DNA Cutting DNA Restriction endonuclease or restriction enzymes Cellular protection mechanism for infected foreign DNA Recognition and cutting specific

More information

Building DNA Libraries to Explore the Combinatorial Design Space. Dr. Yifan Li Senior Scientist GenScript USA Inc.

Building DNA Libraries to Explore the Combinatorial Design Space. Dr. Yifan Li Senior Scientist GenScript USA Inc. Building DNA Libraries to Explore the Combinatorial Design Space Dr. Yifan Li Senior Scientist GenScript USA Inc. Outline Combinatorial Optimization for Metabolic Pathway Engineering Case Studies for Combinatorial

More information

Enabling Lead Discovery at Epigenetics Targets with RapidFire Mass Spectrometry

Enabling Lead Discovery at Epigenetics Targets with RapidFire Mass Spectrometry Enabling Lead Discovery at Epigenetics Targets with RapidFire Mass Spectrometry Stuart Baddeley Director, Screening and Compound Profiling GlaxoSmithKline R&D Stevenage, UK Overview 1. Introduction to

More information

Recombinational cloning Cell-free protein synthesis system

Recombinational cloning Cell-free protein synthesis system Dr. Sanjeeva Srivastava IIT Bombay Recombinational cloning Cell-free protein synthesis system IIT Bombay 2 1 IIT Bombay 3 A novel site-specific recombination technique to transfer DNA sequences universal

More information

Fig. 1. A schematic illustration of pipeline from gene to drug : integration of virtual and real experiments.

Fig. 1. A schematic illustration of pipeline from gene to drug : integration of virtual and real experiments. 1 Integration of Structure-Based Drug Design and SPR Biosensor Technology in Discovery of New Lead Compounds Alexis S. Ivanov Institute of Biomedical Chemistry RAMS, 10, Pogodinskaya str., Moscow, 119121,

More information

PlantForm Corporation

PlantForm Corporation PlantForm Corporation Annual General Meeting September 21, 2010 Dr. Don Stewart President and CEO +1 (416) 452 7242 don.stewart@plantformcorp.com PlantForm Corporation 2010 www.plantformcorp.com The Opportunity

More information

Oncology Product and Platform Partnering Opportunity

Oncology Product and Platform Partnering Opportunity Protein Medicinal Chemistry with an Expanded Genetic Code Oncology Product and Platform Partnering Opportunity April 2017 Ambrx has Made Advances in Proprietary Platform and Titer while Achieving Clinical

More information

Module Overview. Lecture

Module Overview. Lecture Module verview Day 1 2 3 4 5 6 7 8 Lecture Introduction SELEX I: Building a Library SELEX II: Selecting RNA with target functionality SELEX III: Technical advances & problem-solving Characterizing aptamers

More information

Parallel analysis of translated ORF (PLATO)

Parallel analysis of translated ORF (PLATO) Parallel analysis of translated ORF (PLATO) Technical Journal Club 16.04.2013 Mary-Aude Rochat, PhD student Speck group Proteomics Rationale: Increase in the DNA sequence information Understand biological

More information

Meet the CEO developing the Next Generation of Antibody Therapeutics

Meet the CEO developing the Next Generation of Antibody Therapeutics Meet the CEO developing the Next Generation of Antibody Therapeutics Written by Evelyn Warner Editor in Chief, Labiotech.eu Crescendo Biologics has positioned itself as the successor of Cambridge Antibody

More information

Strategic Collaboration with Amgen to develop MP0310

Strategic Collaboration with Amgen to develop MP0310 Strategic Collaboration with Amgen to develop MP0310 Patrick Amstutz, CEO Webcast of Molecular Partners AG, Switzerland (SIX: MOLN) December 19, 2018 2018 Molecular Partners AG Slide 1 Molecular Partners:

More information

CHAPTER 4. Milestones of the drug discovery

CHAPTER 4. Milestones of the drug discovery CHAPTER 4 Milestones of the drug discovery 4.Milestones of the drug discovery: Highlights the importance of the below critical milestones of the drug discovery and correlated to the current research. 1.

More information

The Kinase Knowledgebase

The Kinase Knowledgebase The Kinase Knowledgebase Kevin P. Hambly Product Manager Derek A. Debe, Ph.D. Chief Scientific Officer Outline About Eidogen-Sertanty Kinase Knowledgebase Overview Content Curation Process Data Structure

More information

Laboratory Testing Issues for Protein C, Protein S and Antithrombin Assays

Laboratory Testing Issues for Protein C, Protein S and Antithrombin Assays Laboratory Testing Issues for Protein C, Protein S and Antithrombin Assays Richard A. Marlar Ph.D. University of Oklahoma THSNA Meeting- Chicago, IL April 14-16, 2016 DISCLOSURE Richard A. Marlar, PhD

More information

Personalized CAR-T Immunotherapy Platform

Personalized CAR-T Immunotherapy Platform GLP, GMP, and CLIA-Certified Lab Personalized CAR-T Immunotherapy Platform Accelerate your cancer research and drug discovery Platform Overview 1500 Existing Hybridomas and Antibody Engineering Custom

More information

Structure of a novel phosphotyrosine-binding domain in Hakai that targets E-cadherin

Structure of a novel phosphotyrosine-binding domain in Hakai that targets E-cadherin Manuscript EMBO-2011-79235 Structure of a novel phosphotyrosine-binding domain in Hakai that targets E-cadherin Manjeet Mukherjee, Soah Yee Chow, Permeen Yusoff, Jayaraman Seetharaman, Cherlyn Ng, Saravanan

More information

Hong Kong Pharmacy Conference Feb 2017 WHAT S IN A NAME NOMENCLATURE OF MONOCLONAL ANTIBODIES

Hong Kong Pharmacy Conference Feb 2017 WHAT S IN A NAME NOMENCLATURE OF MONOCLONAL ANTIBODIES Hong Kong Pharmacy Conference Feb 2017 WHAT S IN A NAME NOMENCLATURE OF MONOCLONAL ANTIBODIES Things you get after 20 mins: 1. How drugs are named 2. Monoclonal antibodies (mab) as an example: A. How to

More information

Human Factor V ELISA Kit

Human Factor V ELISA Kit Human Factor V ELISA Kit Catalog No: IRAPKT103 Lot No: SAMPLE INTRODUCTION Factor V (FV) is an essential cofactor of the blood coagulation cascade and circulates in plasma as a large single-chain glycoprotein.

More information

Computational Drug Design

Computational Drug Design Computational Drug Design Univ.-Prof. Dr. Gerhard F. Ecker Pharmacoinformatics Research Group Department of Medicinal Chemistry, University of Vienna Althanstrasse 14, A-1090 Wien, Austria e-mail: gerhard.f.ecker@univie.ac.at;

More information